ClinicalTrials.gov
public full text
Public Domain
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
The purpose of this study is to determine if the investigational treatment (maralixibat) is safe and effective in pediatric participants with Progressive Familial Intrahepatic Cholestasis (PFIC).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Methotrexate for Central Serous Chorioretinopathy Treatment Trial#1124935
- S-adenosylmethionine Plus Choline in Treatment of Patients With Alcoholic Liver Disease#918002
- A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients#993389
- Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation#846395
- Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria#1010967
Record · ID 841408
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive